Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer.

Slutsker L, Hoesly FC, Miller L, Williams LP, Watson JC, Fleming DW.

JAMA. 1990 Jul 11;264(2):213-7.

PMID:
2355442
2.

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

Belongia EA, Hedberg CW, Gleich GJ, White KE, Mayeno AN, Loegering DA, Dunnette SL, Pirie PL, MacDonald KL, Osterholm MT.

N Engl J Med. 1990 Aug 9;323(6):357-65.

3.

L-tryptophan and eosinophilia-myalgia syndrome in New Mexico.

Eidson M, Philen RM, Sewell CM, Voorhees R, Kilbourne EM.

Lancet. 1990 Mar 17;335(8690):645-8.

PMID:
1969024
5.

Update: eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan--United States, as of January 9, 1990.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1990 Jan 12;39(1):14-5. No abstract available.

PMID:
2104651
6.

Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome.

Hill RH Jr, Caudill SP, Philen RM, Bailey SL, Flanders WD, Driskell WJ, Kamb ML, Needham LL, Sampson EJ.

Arch Environ Contam Toxicol. 1993 Jul;25(1):134-42.

PMID:
8346973
7.

Update: eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan--United States.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1989 Dec 8;38(48):842-3. No abstract available.

PMID:
2511412
8.

Eosinophilia-myalgia syndrome. Results of national surveillance.

Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM.

JAMA. 1990 Oct 3;264(13):1698-703.

PMID:
2398610
10.

Update: eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan--United States, through August 24, 1990.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1990 Aug 31;39(34):587-9. No abstract available.

PMID:
2117243
11.

Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.

Kamb ML, Murphy JJ, Jones JL, Caston JC, Nederlof K, Horney LF, Swygert LA, Falk H, Kilbourne EM.

JAMA. 1992 Jan 1;267(1):77-82.

PMID:
1727200
12.

Eosinophilia-myalgia syndrome and L-tryptophan-containing products--New Mexico, Minnesota, Oregon, and New York, 1989.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1989 Nov 24;38(46):785-8. No abstract available.

PMID:
2509891
13.
14.

Eosinophilia-myalgia syndrome in Wisconsin.

Butler JC, Davis JP.

Wis Med J. 1990 Dec;89(12):687-91.

PMID:
2293489
15.

From the Centers for Disease Control. Eosinophilia-myalgia syndrome--New Mexico.

[No authors listed]

JAMA. 1989 Dec 8;262(22):3116. No abstract available.

PMID:
2810660
16.

Eosinophilia-myalgia syndrome--New Mexico.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1989 Nov 17;38(45):765-7. No abstract available.

PMID:
2509886
17.

Eosinophilia-myalgia syndrome: coming to grips with a new illness.

Kilbourne EM.

Epidemiol Rev. 1992;14:16-36.

PMID:
1289111
18.

The cause and pathogenesis of the eosinophilia-myalgia syndrome.

Varga J, Uitto J, Jimenez SA.

Ann Intern Med. 1992 Jan 15;116(2):140-7. Review.

PMID:
1727618
19.

Eosinophilia myalgia syndrome.

[No authors listed]

N Y State J Med. 1990 Jul;90(7):380-2. No abstract available.

PMID:
2385394
20.

Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.

Philen RM, Hill RH Jr, Flanders WD, Caudill SP, Needham L, Sewell L, Sampson EJ, Falk H, Kilbourne EM.

Am J Epidemiol. 1993 Aug 1;138(3):154-9.

PMID:
8356958
Items per page

Supplemental Content

Write to the Help Desk